Retraction: SOX2 Enhances the Migration and Invasion of Ovarian Cancer Cells via Src Kinase (PLoS ONE (2014) 9:6 (e99594) DOI: 10.1371/journal.pone.0099594);SOX2 enhances the migration and invasion of ovarian cancer cells via Src kinase

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Wang, Xiaojie ^a   Ji, Xiaoning ^a   Chen, Jiazhou ^a   Yan, Dong ^a   Zhang, Zhenbo ^a   Wang, Qifeng ^b   Xi, Xiaowei ^a   Feng, Youji ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR SOX2; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OMENTUM; OVARY CARCINOMA; PERITONEUM METASTASIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SEROUS OVARY CARCINOMA; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; VERY ELDERLY; CELL MOTION; CYSTADENOCARCINOMA; ENZYMOLOGY; GENE EXPRESSION; METABOLISM; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; PERITONEUM TUMOR; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; SECONDARY; TUMOR CELL LINE; TUMOR INVASION;

ADULT; AGED; AGED, 80 AND OVER; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYSTADENOCARCINOMA, SEROUS; FEMALE; GENE EXPRESSION; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SOXB1 TRANSCRIPTION FACTORS; SRC-FAMILY KINASES;

EID: 84903288798     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0295163     Document Type: Erratum

References (33)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics. CA Cancer J Clin 62: 10-29.
2. Wang J, Rao S, Chu J, Shen X, Levasseur DN, et al. (2006) A protein interaction network for pluripotency of embryonic stem cells. Nature 444: 364-368. (Pubitemid 44764111)
3. Alonso MM, Diez-Valle R, Manterola L, Rubio A, Liu D, et al. (2011) Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas. PLoS One 6: e26740.
4. Li J, Du L, Yang Y, Wang C, Liu H, et al. (2013) MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2. Cancer Lett 329: 84-90.
5. Jia X, Li X, Xu Y, Zhang S, Mou W, et al. (2011) SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell. J Mol Cell Biol 3: 230-238.
6. Chen Y, Shi L, Zhang L, Li R, Liang J, et al. (2008) The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem 283: 17969-17978.
7. Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, et al. (2012) Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31: 1354-1365.
8. Basu-Roy U, Seo E, Ramanathapuram L, Rapp TB, Perry JA, et al. (2012) Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas. Oncogene 31: 2270-2282.
9. Otsubo T, Akiyama Y, Yanagihara K, Yuasa Y (2008) SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br J Cancer 98: 824-831. (Pubitemid 351272602)
10. Wilbertz T, Wagner P, Petersen K, Stiedl AC, Scheble VJ, et al. (2011) SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Mod Pathol 24: 944-953.
11. Ye F, Li Y, Hu Y, Zhou C, Chen H (2011) Expression of Sox2 in human ovarian epithelial carcinoma. J Cancer Res Clin Oncol 137: 131-137.
12. Zhang J, Chang DY, Mercado-Uribe I, Liu J (2012) Sex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma. Hum Pathol 43: 1405-1412.
13. Bareiss PM, Paczulla A, Wang H, Schairer R, Wiehr S, et al. (2013) SOX2 expression associates with stem cell state in human ovarian carcinoma. Cancer Res 73: 5544-5555.
14. Lou X, Han X, Jin C, Tian W, Yu W, et al. (2013) SOX2 targets fibronectin 1 to promote cell migration and invasion in ovarian cancer: new molecular leads for therapeutic intervention. OMICS 17: 510-518.
15. Zhang ZB, Zhu YP, Lai YL, Wu XM, Feng ZZ, et al.(2013) Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway. Int J Oncol 43:1192-1204.
16. Casey RC, Oegema Jr TR, Skubitz KM, Pambuccian SE, Grindle SM, et al. (2003) Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cells. Clin Exp Metastasis 20: 143-152. (Pubitemid 36403279)
17. Ai M, Liang K, Lu Y, Qiu S, Fan Z (2013) Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition. Cancer Biol Ther 14: 237-245.
18. Kim LC, Song L, Haura EB (2009) Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol 6: 587-595.
19. Jung J, Kim HY, Kim M, Sohn K, Kim M, et al. (2011) Translationally controlled tumor protein induces human breast epithelial cell transformation through the activation of Src. Oncogene 30:2264-2274.
20. Yu HS, Lin TH, Tang CH (2013) Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKCdelta/c-Src dependent signaling pathway. Prostate 73: 89-100.
21. Baker AM, Cox TR, Bird D, Lang G, Murray GI, et al. (2011) The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer. J Natl Cancer Inst 103: 407-424.
22. Bertotti A, Bracco C, Girolami F, Torti D, Gastaldi S, et al. (2010) Inhibition of Src impairs the growth of met-addicted gastric tumors. Clin Cancer Res 16:3933-3943.
23. Kelber JA, Reno T, Kaushal S, Metildi C, Wright T, et al. (2012) KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer. Cancer Res 72: 2554-2564.
24. Singh S, Trevino J, Bora-Singhal N, Coppola D, Haura E, et al. (2012) EGFR/ Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. Mol Cancer 11: 73.
25. Zhang P, Guo A, Possemato A, Wang C, Beard L, et al. (2013) Identification and functional characterization of p130Cas as a substrate of protein tyrosine phosphatase nonreceptor 14. Oncogene 32: 2087-2095.
26. Brabek J, Constancio SS, Siesser PF, Shin NY, Pozzi A, et al. (2005) Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells. Mol Cancer Res 3: 307-315. (Pubitemid 40905622)
27. Tikhmyanova N, Little JL, Golemis EA. (2010) CAS proteins in normal and pathological cell growth control. Cell Mol Life Sci 67: 1025-1048.
28. Wang PS, Chou FS, Porchia L, Saji M, Pinzone JJ. (2008) Troglitazone inhibits cell migration, adhesion, and spreading by modulating cytoskeletal rearrangement in human breast cancer cells. Mol Carcinog 47: 905-915.
29. Schlaepfer DD, Mitra SK. (2004) Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 14: 92-101. (Pubitemid 38167483)
30. Kline CL, Olson TL, Irby RB. (2009) Src activity alters alpha3 integrin expression in colon tumor cells. Clin Exp Metastasis 26: 77-87.
31. Ahmed N, Riley C, Rice G, Quinn M. (2005) Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. Clin Exp Metastasis 22: 391-402. (Pubitemid 41609298)
32. Di Stefano P, Leal MP, Tornillo G, Bisaro B, Repetto D, et al. (2011) The adaptor proteins p140CAP and p130CAS as molecular hubs in cell migration and invasion of cancer cells. Am J Cancer Res 1: 663-673.
33. Kang YS, Kim W, Huh YH, Bae J, Kim JS, et al. (2011) P130Cas attenuates epidermal growth factor (EGF) receptor internalization by modulating EGF-triggered dynamin phosphorylation. PLoS One 6: e20125.